United States

Pharmos' levotofisopam trial in gout earns positive results

Friday, May 18, 2012 12:52 PM

Pharmos, a biopharmaceutical company based in Iselin, N.J., has successfully completed a proof-of-concept clinical trial using its compound levotofisopam (S-tofisopam) to treat patients with hyperuricemia and gout.

More... »

KPCB closes $525 million fund

Friday, May 18, 2012 12:30 PM

Kleiner Perkins Caufield & Byers (KPCB) has successfully closed the KPCB 15, a $525 million venture capital fund focusing on investments in early-stage digital consumer and enterprise, green tech and life sciences companies.

More... »

City of Hope finds potential cure for type 1 diabetes

Friday, May 18, 2012 10:11 AM

City of Hope, a research, treatment and education center for cancer, diabetes and other life-threatening diseases based in Duarte, Calif., has developed a combination therapy to treat late-stage type 1 diabetes (T1D) that appears to offer a potential lifetime cure for the disease without toxic side effects. The laboratory study was published in the May 9, 2012, edition of Science Translational Medicine.

More... »

Synthetic Biologics appoints Carol Reed as senior vice president

Thursday, May 17, 2012 11:12 AM

Synthetic Biologics, an Ann Arbor, Mich.-based developer of synthetic DNA-based therapeutics and disease-modifying medicines for serious illnesses, has appointed Carol Reed, M.D., as senior vice president of clinical & regulatory affairs.

More... »

Insmed appoints Hayden, Jr. as executive chairman

Thursday, May 17, 2012 10:45 AM

Insmed, a Monmouth Junction, N.J.-based biopharmaceutical company focused on inhalants, has appointed Donald J. Hayden, Jr. as executive chairman of the company's board of directors.

More... »

Elevation Pharma releases positive phase IIb results in COPD

Thursday, May 17, 2012 10:31 AM

Elevation Pharmaceuticals, a San Diego-based company focused on the development of new aerosol therapies, has released positive results from a phase IIb study of EP-101 in patients with chronic obstructive pulmonary disease (COPD), a progressive disease of chronic bronchitis and emphysema.

More... »

Achillion receives Fast Track for Hep C drug

Thursday, May 17, 2012 10:15 AM

The FDA has granted Fast Track designation to Achillion Pharmaceuticals’ ACH-3102 as part of an interferon-free regimen for the treatment of chronic hepatitis C (HCV).

More... »

Promedior names Suzanne L. Bruhn president and CEO

Wednesday, May 16, 2012 10:08 AM

Promedior, a Malvern, Penn.-based clinical stage biotech developing novel biologic therapeutics for the treatment of fibrosis, has appointed Suzanne L. Bruhn, Ph.D., as president, CEO and to the board of directors.

More... »

Cornerstone Therapeutics to acquire EKR Therapeutics

Wednesday, May 16, 2012 09:50 AM

Cornerstone Therapeutics, a specialty pharmaceutical company based in Cary, N.C., will acquire EKR Therapeutics, a Bedminster, N.J-based privately-held specialty pharmaceutical company focused on the acute-care hospital setting.

More... »

Obama administration presents national plan to fight Alzheimer’s

Wednesday, May 16, 2012 09:23 AM

Health and Human Services secretary Kathleen Sebelius has released an ambitious national plan to fight Alzheimer’s disease, named “The National Plan to Address Alzheimer’s Disease.”

More... »